Pregnancy Outcomes Following Myomectomy

NCT ID: NCT06474065

Last Updated: 2026-01-23

Basic Information

• Recruitment Status: COMPLETED
• Total Enrollment: 150 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2024-06-28
• Study Completion Date: 2025-12-30

Brief Summary

The most prevalent genital pathology, uterine fibroids have a detrimental impact on the health of women. Fibroid symptoms are typically more impactful on females and frequently require uterine excision. Although contentious in terms of how it affects pregnancy outcomes, hysteroscopic, laparoscopic, or laparotomic myomectomy has always been a necessary and suitable procedure for the patient's health. Numerous studies have been conducted on the topic, but no clear findings have been reached.

The goal of this observational study is to investigate the pregnancy outcomes after hysteroscopic, laparoscopic, laparotomic myomectomies in female patients affected by fibroids. The main questions it aims to answer are:

To investigate pregnancy outcomes in relation to surgical approach used for myomectomy.

To investigate whether pregnancy outcome is different in relation to time when myomectomy was performed: on a pregnant uterus or on a non-gravid uterus.

If there is a comparison group: Researchers will compare a group of patients unsubmitted to surgery, to see the difference with the operated patients.

Participants will follow up, to evaluate the possible pregnancy complications, the intraoperative complications and other perinatal and post-operative complications.

Detailed Description

AIMS:

1. To investigate pregnancy outcomes in relation to surgical approach used for myomectomy.

2. To investigate if pregnancy outcome is different in relation to time when myomectomy was performed: on a gravid uterus or on a non-gravid uterus

Patients enrolled are divided in three major groups:

• Group A: myomectomy outside of pregnancy-A1 hysteroscopic; A2 laparoscopic; A3 laparotomy
• Group B: myomectomy during CS: B1 trans-endometrial; B2 serosal
• Group C: control group with repeated CS

INCLUSION CRITERIA:

1. women of reproductive age (up to 45 yrs)-all groups

2. women who had myomectomy (group A and B)/CS (group C) at least two years before the enrolment

3. myomas 30 mm in size and larger (groups A and B)

4. Study groups: myomectomy performed as hysteroscopic/laparoscopic/laparotomic myomectomy or cesarean myomectomy, both using transendometrial or serosal approach: gravida 2 para 2 or gravida 1 para 1 [groups A1, A2, A3 and groups B1 and B2]

5. Control group: women who had cesarean section in their second pregnancy-para 2 gravida 2, at least two years after the CS [group C]

EXCLUSION CRITERIA:

1. any previous surgery on reproductive organs except myomectomy

2. any additional operation during cesarean myomectomy procedure except cesarean section

3. history of endometriosis or PID

4. coagulation disorders

5. previous treatment for any malignant disease

6. previous GTD

7. premature ovarian failure or any kind of ovarian insufficiency necessitating oocyte donation

8. systemic diseases: IBD, MS, DM

DATA TO COLLECT:

1. age

2. years after myomectomy or CS(for group C)

3. gravidity

4. parity

5. BMI

6. myoma characteristics (size and type)

7. myomectomy procedure

8. gestational week at delivery

9. primary indication for CS

10. fetal position

11. placental pathology

12. preoperative hematologic values

13. postoperative hematologic values

14. duration of the CS

15. myoma recurrence in groups A and B

16. uterine rupture

17. perioperative transfusion

18. febrile morbidity

19. postoperative hospitalization in days

20. PPH

21. cause of PPH

22. uterine atony

23. relaparotomy

24. hysterectomy

25. blood vessels ligation

26. fetal presentation: cephalic/other

27. neonatal body weight

28. Apgar score

OUTCOMES:

1. pregnancy complications

1. placental pathology: placenta previa, placental abruption, PAS

2. PPROM (gestational age)

3. abnormal presentation: cephalic/other

4. uterine rupture: complete/incomplete

5. preterm/term delivery (gestational age at delivery)

2. intraoperative complications

1. intraabdominal adhesions/PAI score

2. surgery complications: Claven Dindo classification

3. other complications:

1. neonatal outcome,

2. duration of maternal hospitalization,

3. primary or secondary PPH

4. primary or secondary PPH

5. relaparotomy

6. peripartum hysterectomy,

7. ligation of major blood vessels (uterine, ovarian, iliac)

The study will be conducted as a multicentric observational study including cesarean section deliveries in each participating center. In each participating center, one person will be in charge for data collection and filling the SPSS database after obtaining the approval of the local Ethic Committee. As the study is observational and all the procedures will be conducted according to the local practice, informed consent from patients is not necessary.

Following data collection and termination of the study, a single researcher will oversee the SPSS data collection for all the participating centers, checking the quality of data and submitting it for statistical analysis.

Conditions

Uterine Fibroid; Pregnancy Complications; Reproductive Issues; Reproductive Sterility

Study Design

• Observational Model Type: CASE_CONTROL
• Study Time Perspective: PROSPECTIVE

Study Groups

Treated patiens' Group as Group 1

Patients submitted to hysteroscopic, laparoscopic or laparotomic myomectomy

Myomectomy

Intervention Type: PROCEDURE

Patients submitted to operation of fibroids removal

Untreated patiens' Group as Group 2

Control group - unoperated patients

No interventions assigned to this group

Interventions

Myomectomy

Patients submitted to operation of fibroids removal

Intervention Type: PROCEDURE

Eligibility Criteria

Inclusion Criteria

1. women of reproductive age (up to 45 yrs)-all groups

2. women who had myomectomy (group A and B)/CS (group C) at least two years before the enrolment

3. myomas 30 mm in size and larger (groups A and B)

4. Study groups: myomectomy performed as hysteroscopic/laparoscopic/laparotomic myomectomy or cesarean myomectomy, both using transendometrial or serosal approach: gravida 2 para 2 or gravida 1 para 1 [groups A1, A2, A3 and groups B1 and B2]

5. Control group: women who had cesarean section in their second pregnancy-para 2 gravida 2, at least two years after the CS [group C]

Exclusion Criteria

1. any previous surgery on reproductive organs except myomectomy

2. any additional operation during cesarean myomectomy procedure except cesarean section

3. history of endometriosis or PID

4. coagulation disorders

5. previous treatment for any malignant disease

6. previous GTD

7. premature ovarian failure or any kind of ovarian insufficiency necessitating oocyte donation

8. systemic diseases: IBD, MS, DM

• Minimum Eligible Age: 25 Years
• Maximum Eligible Age: 45 Years
• Eligible Sex: FEMALE
• Accepts Healthy Volunteers: Yes

Sponsors

Centro di Ricerca Clinica Salentino

NETWORK

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Andrea Tinelli, MD

Role: PRINCIPAL_INVESTIGATOR

Centro di Ricerca Clinica Salentino

Locations

Andrea Tinelli

Lecce, Le, Italy

Countries

Italy

References

Hatirnaz S, Guler O, Basbug A, Cetinkaya MB, Kanat-Pektas M, Bakay K, Celik S, Senturk S, Soyer-Caliskan C, Gurcaglar A, Sahin B, Kalkan U, Celik H, Kalyoncu S, Biyik I, Yassa M, Erol O, Akarsu S, Turhan U, Ulubasoglu H, Sparic R, Tinelli A. A Comparative Multicentric Study on Serosal and Endometrial Myomectomy During Cesarean Section: Surgical Outcomes. J Invest Surg. 2021 Jul;34(7):687-694. doi: 10.1080/08941939.2020.1725188. Epub 2020 Feb 17.

Reference Type: RESULT

PMID: 32064967 (View on PubMed)

Sparic R, Andric L, Guler O, Malvasi A, Babovic I, Hatirnaz S, Dellino M, Tinelli A. Cesarean Myomectomy: Reflections on Clinical and Surgical Controversies between a New Trans-Decidual Technique vs. Traditional Method. Medicina (Kaunas). 2024 Apr 8;60(4):609. doi: 10.3390/medicina60040609.

Reference Type: RESULT

PMID: 38674255 (View on PubMed)

Hatirnaz S, Guler O, Basaranoglu S, Tokgoz C, Kilic GS. Endometrial myomectomy: a novel surgical method during cesarean section. J Matern Fetal Neonatal Med. 2018 Feb;31(4):433-438. doi: 10.1080/14767058.2017.1286320. Epub 2017 Feb 9.

Reference Type: RESULT

PMID: 28114870 (View on PubMed)

Tinelli A, Kosmas I, Medvediev MV, Malvasi A, Morciano A, Sparic R, Mynbaev OA. Myomectomy in adult women of reproductive age: a propensity score-matched study for pregnancy rates. Arch Gynecol Obstet. 2023 Oct;308(4):1351-1360. doi: 10.1007/s00404-023-07135-0. Epub 2023 Jul 14.

Reference Type: RESULT

PMID: 37450263 (View on PubMed)

Tinelli A, Hurst BS, Hudelist G, Tsin DA, Stark M, Mettler L, Guido M, Malvasi A. Laparoscopic myomectomy focusing on the myoma pseudocapsule: technical and outcome reports. Hum Reprod. 2012 Feb;27(2):427-35. doi: 10.1093/humrep/der369. Epub 2011 Nov 16.

Reference Type: RESULT

PMID: 22095838 (View on PubMed)

Sparic R, Papoutsis D, Bukumiric Z, Kadija S, Spremovic Radjenovic S, Malvasi A, Lackovic M, Tinelli A. The incidence of and risk factors for complications when removing a single uterine fibroid during cesarean section: a retrospective study with use of two comparison groups. J Matern Fetal Neonatal Med. 2020 Oct;33(19):3258-3265. doi: 10.1080/14767058.2019.1570124. Epub 2019 Jan 30.

Reference Type: RESULT

PMID: 30700185 (View on PubMed)

Tinelli A, Malvasi A, Mynbaev OA, Barbera A, Perrone E, Guido M, Kosmas I, Stark M. The surgical outcome of intracapsular cesarean myomectomy. A match control study. J Matern Fetal Neonatal Med. 2014 Jan;27(1):66-71. doi: 10.3109/14767058.2013.804052. Epub 2013 Jun 20.

Reference Type: RESULT

PMID: 23662726 (View on PubMed)

Sparic R, Malvasi A, Kadija S, Stefanovic A, Radjenovic SS, Popovic J, Pavic A, Tinelli A. Safety of cesarean myomectomy in women with single anterior wall and lower uterine segment myomas. J Matern Fetal Neonatal Med. 2018 Aug;31(15):1972-1975. doi: 10.1080/14767058.2017.1333096. Epub 2017 Jun 6.

Reference Type: RESULT

PMID: 28585458 (View on PubMed)

Tinelli A, Favilli A, Lasmar RB, Mazzon I, Gerli S, Xue X, Malvasi A. The importance of pseudocapsule preservation during hysteroscopic myomectomy. Eur J Obstet Gynecol Reprod Biol. 2019 Dec;243:179-184. doi: 10.1016/j.ejogrb.2019.09.008. Epub 2019 Sep 17.

Reference Type: RESULT

PMID: 31585677 (View on PubMed)

Tinelli A, Malvasi A, Hurst BS, Tsin DA, Davila F, Dominguez G, Dell'edera D, Cavallotti C, Negro R, Gustapane S, Teigland CM, Mettler L. Surgical management of neurovascular bundle in uterine fibroid pseudocapsule. JSLS. 2012 Jan-Mar;16(1):119-29. doi: 10.4293/108680812X13291597716302.

Reference Type: RESULT

PMID: 22906340 (View on PubMed)

Tinelli A, Mettler L, Malvasi A, Hurst B, Catherino W, Mynbaev OA, Guido M, Alkatout I, Schollmeyer T. Impact of surgical approach on blood loss during intracapsular myomectomy. Minim Invasive Ther Allied Technol. 2014 Mar;23(2):87-95. doi: 10.3109/13645706.2013.839951. Epub 2013 Sep 18.

Reference Type: RESULT

PMID: 24044380 (View on PubMed)

Mettler L, Schollmeyer T, Tinelli A, Malvasi A, Alkatout I. Complications of Uterine Fibroids and Their Management, Surgical Management of Fibroids, Laparoscopy and Hysteroscopy versus Hysterectomy, Haemorrhage, Adhesions, and Complications. Obstet Gynecol Int. 2012;2012:791248. doi: 10.1155/2012/791248. Epub 2012 Apr 9.

Reference Type: RESULT

PMID: 22619681 (View on PubMed)

Tinelli A, Malvasi A, Hudelist G, Cavallotti C, Tsin DA, Schollmeyer T, Bojahr B, Mettler L. Laparoscopic intracapsular myomectomy: comparison of single versus multiple fibroids removal. An institutional experience. J Laparoendosc Adv Surg Tech A. 2010 Oct;20(8):705-11. doi: 10.1089/lap.2010.0082.

Reference Type: RESULT

PMID: 20701546 (View on PubMed)

Other Identifiers

CER 0324

Identifier Type: -

Identifier Source: org_study_id